Harel Insurance Investments & Financial Services Ltd. Has $2.35 Million Stake in DocuSign, Inc. (NASDAQ:DOCU)

Harel Insurance Investments & Financial Services Ltd. increased its stake in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 9,284.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 39,039 shares of the company's stock after acquiring an additional 38,623 shares during the period. Harel Insurance Investments & Financial Services Ltd.'s holdings in DocuSign were worth $2,350,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. MetLife Investment Management LLC bought a new stake in DocuSign in the first quarter worth about $1,337,000. Raymond James Trust N.A. lifted its stake in shares of DocuSign by 27.3% during the 1st quarter. Raymond James Trust N.A. now owns 4,206 shares of the company's stock worth $450,000 after acquiring an additional 901 shares during the last quarter. Sei Investments Co. boosted its holdings in DocuSign by 21.8% during the 1st quarter. Sei Investments Co. now owns 177,214 shares of the company's stock valued at $18,934,000 after acquiring an additional 31,769 shares during the period. National Pension Service grew its position in DocuSign by 25.9% in the 1st quarter. National Pension Service now owns 347,633 shares of the company's stock valued at $37,238,000 after acquiring an additional 71,449 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in DocuSign by 20.3% in the first quarter. Vanguard Group Inc. now owns 17,308,877 shares of the company's stock worth $1,854,127,000 after purchasing an additional 2,917,683 shares during the period. 77.64% of the stock is owned by institutional investors.

Insider Transactions at DocuSign

In other news, insider Stephen Shute sold 15,109 shares of the stock in a transaction on Tuesday, March 19th. The shares were sold at an average price of $57.02, for a total value of $861,515.18. Following the sale, the insider now owns 8,959 shares in the company, valued at $510,842.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, insider Stephen Shute sold 15,109 shares of the company's stock in a transaction dated Tuesday, March 19th. The stock was sold at an average price of $57.02, for a total value of $861,515.18. Following the completion of the transaction, the insider now owns 8,959 shares of the company's stock, valued at approximately $510,842.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Allan C. Thygesen sold 7,680 shares of the firm's stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $61.27, for a total transaction of $470,553.60. Following the completion of the transaction, the chief executive officer now directly owns 111,767 shares in the company, valued at $6,847,964.09. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 54,871 shares of company stock worth $3,176,199. Company insiders own 17.80% of the company's stock.

DocuSign Stock Performance

DOCU traded down $2.23 during trading on Monday, hitting $56.67. The stock had a trading volume of 1,985,389 shares, compared to its average volume of 3,498,229. DocuSign, Inc. has a twelve month low of $38.11 and a twelve month high of $64.76. The stock has a 50 day simple moving average of $55.37 and a two-hundred day simple moving average of $51.73. The company has a market capitalization of $11.64 billion, a PE ratio of 163.62, a PEG ratio of 5.15 and a beta of 0.89.

DocuSign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings results on Thursday, March 7th. The company reported $0.15 EPS for the quarter, beating analysts' consensus estimates of $0.09 by $0.06. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. The company had revenue of $712.39 million during the quarter, compared to analysts' expectations of $698.05 million. On average, equities research analysts anticipate that DocuSign, Inc. will post 0.86 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. JMP Securities reaffirmed a "market outperform" rating and issued a $84.00 price target on shares of DocuSign in a research note on Friday. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $59.00 price target on shares of DocuSign in a research note on Friday. Needham & Company LLC reissued a "hold" rating on shares of DocuSign in a research note on Friday. TheStreet raised DocuSign from a "d+" rating to a "c-" rating in a research report on Tuesday, December 19th. Finally, Wells Fargo & Company dropped their price target on DocuSign from $55.00 to $45.00 and set an "underweight" rating on the stock in a research report on Monday, February 5th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, DocuSign currently has an average rating of "Hold" and an average target price of $60.25.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.